Yoshiaki Chinen
4PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 14, 2021
Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib-based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients.Yuka Kawaji-Kanayama, Tsutomu Kobayashi, Ayako Muramatsu
|Jun 20, 2020
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma.Saeko Kuwahara-Ota, Yuji Shimura, Christian Steinebach
|May 19, 2020
Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma.Yayoi Matsumura-Kimoto, Taku Tsukamoto, Yuji Shimura
|Mar 05, 2019
A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma.Yoshimi Mizuno, Yoshiaki Chinen, Taku Tsukamoto
Pageof 1
